Back
Nuvectis Pharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
NVCT
Nuvectis Pharma, Inc.
Last Price:
$7.41
Seasonality Move:
42.76%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and NVCT is experiencing slight selling pressure.
Nuvectis Pharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.8 | Sell |
| 20-day SMA: | 7.28 | Buy |
| 50-day SMA: | 6.59 | Buy |
| 200-day SMA: | 7.59 | Buy |
| 8-day EMA: | 7.71 | Sell |
| 20-day EMA: | 7.35 | Buy |
| 50-day EMA: | 6.86 | Buy |
| 200-day EMA: | 7.03 | Buy |
Nuvectis Pharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 60.17 | Buy |
| Chaikin Money Flow: | -8539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.28 - 7.8) | Buy |
| Bollinger Bands (100): | (5.86 - 7) | Buy |
Nuvectis Pharma, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nuvectis Pharma, Inc. Stock
Is Nuvectis Pharma, Inc. Stock a Buy?
-
Nuvectis Pharma, Inc. share price is 7.68 while NVCT 8-day simple moving average is 7.80, which is a Sell signal.
-
The stock price of NVCT is 7.68 while Nuvectis Pharma, Inc. 20-day SMA is 7.28, which makes it a Buy.
-
Nuvectis Pharma, Inc. 50-day simple moving average is 6.59 while NVCT share price is 7.68, making it a Buy technically.
-
NVCT stock price is 7.68 and Nuvectis Pharma, Inc. 200-day simple moving average is 7.59, creating a Buy signal.
NVCT Technical Analysis vs Fundamental Analysis
Buy
59
Nuvectis Pharma, Inc. (NVCT)
is a Buy
Is Nuvectis Pharma, Inc. a Buy or a Sell?
-
Nuvectis Pharma, Inc. stock is rated a BuyThe current Nuvectis Pharma, Inc. [NVCT] share price is $7.68. The Score for NVCT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Nuvectis Pharma, Inc. Stock Info
Market Cap:
196.7M
Price in USD:
7.68
Share Volume:
32.2K
Nuvectis Pharma, Inc. 52-Week Range
52-Week High:
11.52
52-Week Low:
5.03
Buy
59
Nuvectis Pharma, Inc. (NVCT)
is a Buy
Nuvectis Pharma, Inc. Share Price Forecast
-
What is the Nuvectis Pharma, Inc. stock price today?The Nuvectis Pharma, Inc. stock price is 7.68 USD today.
-
Will NVCT stock go up or go down?Nuvectis Pharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Nuvectis Pharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nuvectis Pharma, Inc. is not overvalued.
Is Nuvectis Pharma, Inc. Stock a Buy?
-
Nuvectis Pharma, Inc. share price is 7.68 while NVCT 8-day exponential moving average is 7.71, which is a Sell signal.
-
The stock price of NVCT is 7.68 while Nuvectis Pharma, Inc. 20-day EMA is 7.35, which makes it a Buy.
-
Nuvectis Pharma, Inc. 50-day exponential moving average is 6.86 while NVCT share price is 7.68, making it a Buy technically.
-
NVCT stock price is 7.68 and Nuvectis Pharma, Inc. 200-day simple moving average is 7.03, creating a Buy signal.
Technical Analysis of Nuvectis Pharma, Inc.
Should I short Nuvectis Pharma, Inc. stock?
-
NVCT Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting Nuvectis Pharma, Inc. is a Buy
-
Nuvectis Pharma, Inc. Relative Strength Index (RSI) is 60.17, which suggest Nuvectis Pharma, Inc. is overbought
-
The Bollinger Bands (25) for Nuvectis Pharma, Inc. is (6.28 - 7.8), which suggest Nuvectis Pharma, Inc. is a Buy
-
The Bollinger Bands (100) for Nuvectis Pharma, Inc. is (5.86 - 7), which suggest Nuvectis Pharma, Inc. is a Buy
* Nuvectis Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.